Loading...
Loading...
Pro Medicus Ltd./ADR
Pro Medicus Ltd./ADR. Spoken Alpha tracks PMDIY's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks PMDIY's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 70% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PMDIY.
curl https://api.spokenalpha.com/v1/companies/PMDIY| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.40 | $1.70 | +41.1% | -5.6% | -6.9% |
| Q4 FY2026 | $2.55 | $1.98 | +28.9% | +0.4% | +2.6% |
| Q3 FY2026 | $2.41 | $1.86 | +29.7% | -3.3% | -1.4% |
| Q2 FY2026 | $2.33 | $1.74 | +33.9% | -2.9% | -1.0% |
| Q1 FY2025 | $2.69 | $1.96 | +37.2% | -4.8% | -3.2% |
| Q4 FY2025 | $2.75 | $2.02 | +36.3% | -2.1% | -3.6% |
| Q3 FY2025 | $2.45 | $1.83 | +33.8% | -2.3% | -2.0% |
| Q2 FY2025 | $2.57 | $1.91 | +34.4% | -1.1% | +1.3% |
| Q1 FY2024 | $2.57 | $1.88 | +36.7% | +2.1% | -0.5% |
| Q4 FY2024 | $2.40 | $1.88 | +27.8% | +1.8% | +3.4% |